Grow Therapy
Grow Therapy connects insurance-covered patients with therapists through a credentialing and billing platform.
On the record
Checkpoint: Whether new patient app and employer/EAP GTM offset Psychology Today traffic collapse
The call
Grow Therapy has real regulatory cover and scale, but its main patient funnel is breaking just as AI tools and better-funded peers push harder for the same referrals.
Grow Therapy is an online therapy platform that matches people with real, licensed therapists and handles insurance billing. It's hard to copy because therapists need licenses, insurance companies require specific paperwork and credentials, and there are real legal risks if something goes wrong, which pure AI chatbots cannot do. But Grow Therapy is losing ground to rivals like Rula, which is growing twice as fast, and new AI tools like Slingshot AI are starting to send patients directly to therapists without using directories like Psychology Today, where Grow has relied on for customers. The key question is whether Grow can keep growing as fast as Rula and hold onto insurance companies and therapists when AI tools start cutting out the middleman.
Why
01
AI pressure: Slingshot AI, Sonia, Camber, Orchid. AI chat and unbundled discovery apps threaten to intercept patients before they ever hit a directory search. Could AI do the core job? Unlikely.
02
Bigger players: Headway and Rula (Spring Health/Alma consolidation). Rula grows 100% YoY and Headway has 60K+ providers while Grow's Psychology Today referral funnel is collapsing. Could a giant copy it? Probably.
03
What protects it. Insurance credentialing, malpractice liability structure, and 125+ payer contracts covering 220M lives are hard to replicate fast.
What would change this call
Grow's provider count and revenue growth rate through Q4 2026 vs Rula's reported 100% YoY pace. Shows whether Grow is losing the peer growth race after its SEO funnel weakened.
Adoption metrics for Grow's new patient app and employer/EAP channel launched March 2026. Shows whether Grow replaced Psychology Today referral volume with owned channels.
Further acquisitions in therapy-network space following Spring Health's purchase of Alma. Shows whether sector consolidation is squeezing Grow's independent positioning.
Adoption metrics for Grow's new patient app and employer/EAP channel launched March 2026. Shows whether Grow replaced Psychology Today referral volume with owned channels.
Further acquisitions in therapy-network space following Spring Health's purchase of Alma. Shows whether sector consolidation is squeezing Grow's independent positioning.
Key numbers
- $1B+ annual revenue, profitable since 2023
- 26,000 providers, 220M covered lives via 125+ insurers
- $150M Series D at $3B valuation
Named risks
- Primary discovery channel Psychology Today in visible decline, prompting Grow's July 2026 listing retreat.
- Faster-growing peer Rula (100% YoY) and larger peer Headway compete for same providers and payer contracts.
- Consumer complaints over billing, unpaid claims, and a California DA-referred credentials complaint (March 2026).
- Integration execution risk from two 2025-2026 acquisitions plus a brand-new CFO onboarded April 2026.
- Inconsistent investor disclosure in Series D reporting required a public correction.
Rivals, as read in July 2026
| Rival | Direction | Evidence |
|---|---|---|
| Headway | losing to | 60,000+ providers reported as of Sept 2025, the largest network in the category |
| Rula | losing to | Rula growing about 100% YoY at roughly $471M annualized revenue in 2024, per Sacra |
| Spring Health (via Alma acquisition) | contesting | Spring Health reported acquiring peer Alma, signaling sector-wide consolidation as of March 2026 |
| Slingshot AI, Sonia, Camber, Orchid | contesting | AI-native discovery and insurance-automation tools unbundling patient discovery, per Sacra, Sept 2025 |
Questions people ask
- Is Grow Therapy profitable in 2026?
- Grow Therapy has been profitable since 2023, according to CEO statements reported by Crain's New York Business on March 4, 2026, alongside a $3 billion valuation from its March 2026 Series D round.
- Who owns Grow Therapy?
- Grow Therapy is privately held and venture backed, with no parent company. Its March 3, 2026 Series D raised $150M led by TCV and Goldman Sachs Alternatives at a $3 billion valuation, bringing total funding to about $328M.
- Could AI replace therapists at Grow Therapy?
- No. Insurance billing and malpractice liability require a licensed human clinician of record, so Grow Therapy uses AI for documentation and note-taking (about 70% less time per its own March 2026 claim) rather than replacing therapists.
- Who is Grow Therapy's biggest competitor?
- Headway leads the sector with 60,000+ providers as of September 2025, while Rula is growing fastest at about 100% year over year with roughly $471M revenue in 2024, per Sacra. Grow Therapy sits as a strong #2 or #3 by scale.
- How much funding has Grow Therapy raised total?
- As of its March 3, 2026 Series D announcement, Grow Therapy had raised approximately $328M total across Series A ($15M, 2021), B ($75M, 2022), C ($88M, 2024), and D ($150M, 2026), per Yahoo Finance.
- Is Grow Therapy's $1 billion revenue figure real?
- The $1 billion-plus annual revenue figure is a company-disclosed claim reported around the March 3, 2026 Series D announcement, not an independently audited figure, per ainvest.com and BH Business coverage.
Timeline
- 2026-07-15Grow Therapy retreats from Psychology Today directory listings amid referral traffic decline
- 2026-06-22Announces Stanford research partnership on AI safety in mental health crises
- 2026-04-15Appoints Seth Bressack, former Shopify finance leader, as first CFO
- 2026-03-03Closes $150M Series D led by TCV and Goldman Sachs Alternatives at $3B valuation
- 2026-02-10Acquires AI scribe startup Tenor Therapy, previously backed by Sequoia and Greylock
- 2026-01Launches first patient-facing mobile app with AI-assisted journaling
- 2025-09Acquires digital privacy company neosync
- 2025-02-20Launches AI-assisted clinical tools: ambient note-taking and visit summaries
- 2024-04-08Raises $88M Series C led by Sequoia Capital, reaches unicorn status above $1B valuation
- 2020-10Grow Therapy founded in New York, NY
Revision history
22 July 2026
First assessed. Protection under test. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources
- Grow Therapy snags $88M, builds out measurement-based care tech (2024-04-08)
- Grow Therapy raises $88M to revamp mental health and the MSO playbook
- Grow therapy announces $75M Series B raise (2025-10-01)
- Grow Therapy Raises $88M in Series C, Secures Unicorn Status (2024-04-08)
- Mental health startup Grow Therapy valued at $3 billion in latest fundraise (2026-03-03)
- Mental health startup Grow Therapy hits $3B valuation (2026-03-04)
- Mental Health Startup Grow Therapy Hits $3 Billion Valuation (2026-03-03)
- Grow Therapy Appoints Seth Bressack Chief Financial Officer (2026-04-15)
- Grow Therapy Raises $150 Million in Series D As It Solidifies New Flagship Partnerships (2026-03-03)
- Grow Therapy - Headcount, Funding & Open Jobs (2026-07-08)
- Grow Therapy Launches AI-assisted Clinical Tools to Enhance Client and Provider Experience (2025-02-20)
- With $1B in Revenue, Grow Therapy Lands $150M Series D (2026-03-03)